New Study Reveals Potential Pancreatic Cancer Treatment Combining Keto Diet and Drug

Researchers discover that a ketogenic diet paired with the drug eFT508 can inhibit pancreatic tumor growth in mice.

The study was conducted by scientists at UC San Francisco, focusing on the protein eIF4E's role in fat metabolism.
Pancreatic tumors in mice stopped growing when treated with eFT508 and a ketogenic diet, blocking their fat metabolism.
The drug eFT508, also known as tomivosertib, is currently in clinical trials and has shown promise in combination with dietary interventions.
Pancreatic Cancer UK cautions against dietary changes for patients without medical advice, as the study is in early stages.
Researchers believe this approach could lead to new, personalized cancer treatments targeting metabolic vulnerabilities.